Logo

Siemens Healthineers Strengthens Technology Position in Immunoassay Point-of-Care Testing

Share this
Siemens Healthineers Strengthens Technology Position in Immunoassay Point-of-Care Testing

M&A

Siemens Healthineers Strengthens Technology Position in Immunoassay Point-of-Care Testing

Malvern, PA?|??Jul 29, 2019

? Minicare BV offers handheld technology to deliver immunoassay testing at the point of care.
? Siemens Healthineers aims to transform care delivery and improve patient experience for in vitro diagnostics with innovative technology to advance point-of-care testing.

Siemens Healthineers announced today the acquisition of Minicare BV. Minicare BV is a privately held company with nearly 15 employees and is based in Eindhoven, Netherlands. Minicare BV?s handheld technology offers Siemens Healthineers the capability to miniaturize immunoassay testing for point-of-care applications. The deal closed on July 2, 2019. Financial details of the transaction were not disclosed.

?Next-generation point-of-care testing from Siemens Healthineers will bring healthcare providers the capability to expedite immunoassay test results and enable timelier patient care,? said Christoph Pedain, PhD, Head of Point of Care Diagnostics, Siemens Healthineers. ?By integrating the analyte detection technology Minicare BV has developed with Siemens Healthineers engineering expertise and global reach, our vision for healthcare providers is that they will be able to deliver quality immunoassay testing in the right setting for their patients at the right time.?

Contact for journalists
Kimberly Nissen, Siemens Healthineers
Phone: +1 610 448-6355; Email: Kimberly.Nissen@siemens-healthineers.com

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of ?13.4 billion and adjusted profit of ?2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens-healthineers.com.

Share this article on WhatsApp, LinkedIn and Twitter



Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions